Advanced Search

 

Study ID Status Title Patient Level Data
116559 Recruiting Summary Document Analysis Plan for GSK1550188 Study BEL116559 Pooled Analysis of Belimumab Elderly Patients
116564 Completed A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) versus Primaquine in the Treatment of Subjects with Plasmodium vivax Malaria
116566 Not yet recruiting Immunogenicity and safety study of two different formulations of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine, Rotarix in healthy infants
116570 Completed Evaluation of immunogenicity and safety of GSK Biologicals' Tdap booster vaccine (Boostrix™) in young adults, administered 10 years after previous Tdap boosting
116571 Completed A 12-week randomised, double-blind, parallel-group study to evaluate the anti-inflammatory effects of ADOAIR® 50/250mcg twice daily compared with placebo twice daily in Japanese subjects with chronic obstructive pulmonary disease (COPD)
116572 Completed A randomised, double-blind, double dummy, 3 way cross-over study evaluating the effects of ADOAIR 50/250mcg twice daily plus tiotropium bromide 18mcg once daily compared with the individual treatments (tiotropium bromide 18mcg alone and ADOAIR 50/250mcg alone) in the treatment of Japanese subjects with COPD Study Listed on ClinicalStudyDataRequest.com
116576 Completed A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae
116581 Completed A four-week Phase IIa, randomized, double-blind, placebo-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of GSK1278863 in subjects with anemia associated with chronic kidney disease who are not taking recombinant human erythropoietin and are not undergoing dialysis Study Listed on ClinicalStudyDataRequest.com
116582 Completed A four-week, Phase IIa, randomized, active-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of switching subjects from a stable dose of recombinant human erythropoietin to GSK1278863 in hemodialysis-dependent subjects with anemia associated with chronic kidney disease Study Listed on ClinicalStudyDataRequest.com
116585 Completed A single-center, randomized, open-label, crossover study to assess the relative bioavailability of new formulations of GSK1265744 in healthy adult subjects
116586 Completed A Phase II, Open label, Single arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients with Chronic Lymphocytic Leukemia
116589 Recruiting Anti-Xa activity of fondaparinux for venous thromboembolism (VTE) treatment
116592 Completed A randomized, double-blind, placebo-controlled cross-over study to determine the bronchodilator effect of a single dose of fluticasone furoate (FF)/ vilanterol (VI) 100/25 mcg combination administered in the morning in adult patients with asthma Study Listed on ClinicalStudyDataRequest.com
116595 Completed A Single Dose, Open Label, Randomized, Balanced, Crossover Study to Assess the Relative Bioavailability of ThreeFormulations and Food Effect on GSK1322322 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
116601 Completed A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
116602 Completed Risk of solid organ transplant rejection following vaccination with Pandemrix™ in the United Kingdom
116604 Active not recruiting PGx6039 PGx Investigation of Pyrexia in Subjects Receiving GSK2118436 Monotherapy
116606 Recruiting An epidemiological surveillance study to evaluate the incidence of dengue in endemic regions of Brazil
116610 Completed An Open Label, Single Center, Adaptive Phase I Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (ronacaleret; a calcium sensing receptor antagonist)
116613 Recruiting Phase II Biomarker Study Evaluating The Upfront Combination Of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus The Combination After Eight Weeks Of Monotherapy With Dabrafenib Or Trametinib In Patients With Metastatic And Unresectable Stage III Or IV Melanoma Harbouring An Activating BRAF Mutation
116615 Completed Bioequivalence Study for an Isotretinoin Pharmaceutical Preparation - capsules. Crossover, randomized, single dose, two treatments, two periods and two sequences with meal (breakfast) study
116617 Completed A Single-Centre, Double-Blind, Placebo Controlled Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2269557 as a Dry Powder in Healthy Subjects who Smoke Cigarettes
116621 Completed An observational study to estimate the disease burden of rotavirus gastroenteritis in infants/children less than five years of age in primary care settings, in Bulgaria and Latvia
116623 Completed A double-blind [sponsor unblinded], randomized, placebo-controlled, staggered-parallel study to investigate the safety, tolerability, and pharmacodynamics of GSK2890457 in healthy volunteers and subjects with type 2 diabetes
116628 Completed A Single Center Phase 1 Double Blind Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.